Chicago, IL, United States of America

Roslyn Cohen



Average Co-Inventor Count = 2.3

ph-index = 4

Forward Citations = 211(Granted Patents)


Company Filing History:


Years Active: 2007-2011

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations in Hemostasis: The Contributions of Roslyn Cohen

Introduction

Roslyn Cohen is a prominent inventor based in Chicago, IL, known for her significant contributions to the field of hemostasis. With a total of five patents to her name, she has made remarkable advancements in the monitoring and analysis of blood coagulation processes. Her work has been instrumental in improving patient care and treatment outcomes in various medical settings.

Latest Patents

Cohen's latest patents include a "Protocol for Monitoring Direct Thrombin Inhibition," which utilizes a hemostasis analyzer, such as the Thrombelastograph® (TEG®) hemostasis analyzer. This innovative device measures the hemostasis process in real time, from the initial fibrin formation through platelet-fibrin interaction and lysis, generating crucial blood hemostasis parameters. These parameters allow for the evaluation of hemostasis therapies, including anticoagulation therapies like direct thrombin inhibition therapies. Another notable patent is the "Protocol and Apparatus for Determining Heparin-Induced Thrombocytopenia." This invention also employs the Thrombelastograph® (TEG®) hemostasis analyzer to continuously measure the hemostasis process and determine the heparin-induced thrombocytopenia II complex (HiT II).

Career Highlights

Throughout her career, Cohen has worked with esteemed organizations such as Haemoscope Corporation and Cora Healthcare, Inc. Her expertise in hemostasis and blood analysis has positioned her as a leader in her field. She has dedicated her career to advancing medical technology and improving patient outcomes through her innovative inventions.

Collaborations

Cohen has collaborated with notable professionals in her field, including Eli Cohen and Roger C. Carroll. These partnerships have further enhanced her research and development efforts, leading to groundbreaking advancements in hemostasis technology.

Conclusion

Roslyn Cohen's contributions to the field of hemostasis through her innovative patents and collaborations have significantly impacted medical practices. Her work continues to pave the way for advancements in patient care and treatment methodologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…